Physician profile
Cody Hudson
NPI 1518722743
$1,918.38
in general payments reported to CMS, 2019-2025
19 companies · $1,116 in 2025
The $1,116 reported for 2025 was more than what 88% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $802 · 2025: $1,116.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,918.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,918.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $274.54 | 2025 | Lokelma, Farxiga |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $220.33 | 2024-2025 | Lifevest |
| Amgen INC. | $210.12 | 2024-2025 | Repatha, Repatha |
| Novartis Pharmaceuticals Corporation | $175.50 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.30 | 2024-2025 | Jardiance |
| Boston Scientific Corporation | $141.62 | 2024-2025 | Avvigo Guidance System, Lux-Dx Insertable Cardiac Monitor |
| Heartflow, INC. | $121.81 | 2024-2025 | |
| Novo Nordisk INC | $111.48 | 2024-2025 | Wegovy, Rybelsus, Ozempic |
| Biobeat USA INC. | $81.65 | 2024 | Bb-613 Bpm Kit |
| Lexicon Pharmaceuticals, INC. | $72.61 | 2024 | |
| Genzyme Corporation | $67.46 | 2024 | |
| Pfizer INC. | $62.81 | 2024-2025 | |
| Medtronic, INC. | $52.38 | 2025 | Corevalve Evolut R |
| Merck Sharp & Dohme LLC | $46.19 | 2024-2025 | Verquvo |
| Biosense Webster, INC. | $34.25 | 2025 | Carto 3 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $32.30 | 2024 | Xarelto |
| Cvrx, INC. | $25.33 | 2024 | Barostim Neo System |
| Inspire Medical Systems, INC. | $21.68 | 2025 | Inspire |
| Alnylam Pharmaceuticals INC. | $19.02 | 2025 | Amvuttra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cody Hudson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.